Details for New Drug Application (NDA): 213273
✉ Email this page to a colleague
The generic ingredient in ENALAPRIL MALEATE is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.
Summary for 213273
Tradename: | ENALAPRIL MALEATE |
Applicant: | Prinston Inc |
Ingredient: | enalapril maleate |
Patents: | 0 |
Pharmacology for NDA: 213273
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Physiological Effect | Decreased Blood Pressure |
Medical Subject Heading (MeSH) Categories for 213273
Suppliers and Packaging for NDA: 213273
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 213273 | ANDA | Solco Healthcare US, LLC | 43547-545 | 43547-545-03 | 30 TABLET in 1 BOTTLE (43547-545-03) |
ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 213273 | ANDA | Solco Healthcare US, LLC | 43547-545 | 43547-545-09 | 90 TABLET in 1 BOTTLE (43547-545-09) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Jul 7, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jul 7, 2022 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jul 7, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription